Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010

Emerging Infectious Diseases

Volumn 18, Issue 1, 2012, Pages 120-124

  Papenburg, Jesse ^a,b   Carbonneau, Julie ^b   Hamelin, Marie Ève ^b   Isabel, Sandra ^b   Bouhy, Xavier ^b   Ohoumanne, Najwa ^c   Déry, Pierre ^b   Paes, Bosco A ^d   Corbeil, Jacques ^b   Bergeron, Michel G ^b   de Serres, Gaston ^c   Boivin, Guy ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d MCMASTER CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BRONCHIOLITIS; CANADA; COHORT ANALYSIS; COMORBIDITY; GENE AMPLIFICATION; GENE FUSION; GENE SEQUENCE; HUMAN; IMMUNOPROPHYLAXIS; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PEDIATRICS; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RNA EXTRACTION;

CANADA; COHORT STUDIES; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL FUSION PROTEINS;

EID: 84856578799     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1801.110515     Document Type: Article

References (15)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010; 375:1545-55. doi:10.1016/S0140- 6736(10)60206-1
2. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003;143:S112-7. doi:10.1067/S0022-3476(03)00508-0
3. Collins PL, Crowe JE. Respiratory syncytial virus and metapneumovirus. In: Knipe DM, Howley PM, editors. Field's virology.,5th ed. New York: Lippincott Williams and Wilkins; 2007. p. 1601-46.
4. Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, et al. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology. 1998;252:373-5. doi:10.1006/viro.1998.9462
5. Huang K, Incognito L, Cheng X, Ulbrandt ND, Wu H. Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion. J Virol. 2010;84:8132-40. doi:10.1128/JVI.02699-09
6. Committee on Infectious Diseases. From the American Academy of Pediatrics: policy statements-modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009;124:1694-701. doi:10.1542/peds.2009-2345
7. Zhao X, Chen FP, Megaw AG, Sullender WM. Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants. J Infect Dis. 2004;190:1941-6. doi:10.1086/425515
8. Adams O, Bonzel L, Kovacevic A, Mayatepek E, Hoehn T, Vogel M. Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clin Infect Dis. 2010;51:185-8. doi:10.1086/653534
9. Zhu Q, McAuliffe JM, Patel NK, Palmer-Hill FJ, Yang CF, Liang B, et al. Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. J Infect Dis. 2011;203:674-82. doi:10.1093/infdis/jiq100
10. Kim YK, Choi EH, Lee HJ. Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus. J Med Virol. 2007;79:820-8. doi:10.1002/jmv.20891
11. Zheng H, Storch GA, Zang C, Peret TC, Park CS, Anderson LJ. Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus. Virus Res. 1999;59:89-99. doi:10.1016/S0168-1702(98)00132-4
12. Gilca R, De Serres G, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis. 2006;193:54-8. doi:10.1086/498526
13. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, et al. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis. 2000;181:1891-6. doi:10.1086/315508
14. Raymond F, Carbonneau J, Boucher N, Robitaille L, Boisvert S, Wu WK, et al. Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol. 2009;47:743-50. doi:10.1128/JCM.01297-08
15. Boivin G, Caouette G, Frenette L, Carbonneau J, Ouakki M, De Serres G. Human respiratory syncytial virus and other viral infections in infants receiving palivizumab. J Clin Virol. 2008;42:52-7. doi:10.1016/j.jcv.2007.11.012